Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development.
Ontology highlight
ABSTRACT: Mesenchymal stem cells (MSCs) have regenerative properties, but recently they were also found to have immunomodulatory capacities. We therefore investigated whether MSCs could reduce atherosclerosis, which is determined by dyslipidaemia and chronic inflammation. We adoptively transferred MSCs into low-density lipoprotein-receptor knockout mice and put these on a Western-type diet to induce atherosclerosis. Initially after treatment, we found higher levels of circulating regulatory T cells. In the long-term, overall numbers of effector T cells were reduced by MSC treatment. Moreover, MSC-treated mice displayed a significant 33% reduction in circulating monocytes and a 77% reduction of serum CCL2 levels. Most strikingly, we found a previously unappreciated effect on lipid metabolism. Serum c
SUBMITTER: Frodermann V
PROVIDER: S-EPMC4614841 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA